In last-minute deal, Allergan forks over a hefty $300M to settle pay-for-delay dispute

With AbbVie and Allergan almost ready to wrap up their $63 billion megamerger, both drugmakers are looking to clear any outstanding accounts before the deal closes. And Allergan just agreed to fork over $300 million to resolve one of them.